Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "EHA"

450 News Found

Masina hospital launches a tobacco cessation clinic
Hospitals | April 10, 2022

Masina hospital launches a tobacco cessation clinic

The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention


Sky announces the availability of its geko device on the Indian govt e-marketplace
Medical Device | April 07, 2022

Sky announces the availability of its geko device on the Indian govt e-marketplace

With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)


Good microbiome and probiotics key to good health
Healthcare | April 04, 2022

Good microbiome and probiotics key to good health

The symposium was organized by the Gut Microbiota and Probiotic Science Foundation (India) and Medanta Institute of Education and Research, Gurugram, and Amity University, Gurugram


USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
Biotech | April 03, 2022

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --


Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Biotech | April 03, 2022

Dr. Reddy's and MediCane Health launch medical cannabis in Germany

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021


Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Biotech | April 01, 2022

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product


FDI World Dental Federation releases statement on sustainable oral healthcare
Sustainability | March 31, 2022

FDI World Dental Federation releases statement on sustainable oral healthcare

It paves the way for an industry Code of Good Practice


Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies
Public Health | March 30, 2022

Rotary Club of Delhi South carriers out large-scale relief work across leprosy colonies

India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.


Sun Pharma gets exclusive patent licence for Vortioxetine
News | March 30, 2022

Sun Pharma gets exclusive patent licence for Vortioxetine

Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults